VerifiedFreedom Diagnostics
99.54%
Purity
Passed full QC panel
- Variant
- CJC-1295 No DAC 10mg
- Lot
- CJC01001
- Net Peptide Content
- 9.22 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics
Loading…
Please confirm you are 21 years of age or older to enter.
By entering, you confirm that you are 21 years of age or older.
Valence Labs Research
GHRH Analogue Research Peptide
The Valence Labs catalog material is CJC-1295 No DAC, also described as Modified GRF(1-29). It is a GHRH analogue studied in growth hormone-releasing hormone receptor and GH-axis signaling research.
CJC-1295 No DAC is distinct from long-acting, DAC-containing CJC-1295. Multi-day pharmacokinetics and albumin-binding properties described for DAC-containing CJC-1295 should not be attributed to this No-DAC product, and studies of DAC-containing CJC-1295 should not be read as direct studies of Valence CJC-1295 No DAC.
CJC-1295 No DAC / Modified GRF(1-29) is studied as a GHRH analogue in laboratory research.
Research interest includes GHRH-receptor interaction and related GH-axis signaling questions.
The Modified GRF(1-29) sequence is examined in structure–activity and peptide-stability research without the Drug Affinity Complex (DAC) modification.
This page describes CJC-1295 No DAC / Modified GRF(1-29). It does not describe DAC-containing, long-acting CJC-1295.
Published work on long-acting/DAC-containing CJC-1295 is cited below only to mark that distinction. Those studies should not be treated as evidence that the No-DAC catalog product was studied, or that it shares DAC-associated albumin-binding or multi-day pharmacokinetic properties.
Catalog details for this product.
99.54%
Purity
Passed full QC panel
CJC-1295 No DAC
10mg